MAUREEN JORDEN: Open Payments
NPI 1730589888 · NORWALK, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$464 in 26 payments from 10 companies in 2025. Trend: 2023 $613 · 2024 $623 · 2025 $464
Food & beverage: $464
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $104 |
| ABBVIE INC. | 5 | $94 |
| Lilly USA, LLC | 4 | $71 |
| Novo Nordisk Inc | 3 | $52 |
| Corcept Therapeutics | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Dexcom, Inc. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| PFIZER INC. | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
Products named: Kerendia, UBRELVY, Korlym, JARDIANCE, MOUNJARO, Dexcom G6 Transmitter, VRAYLAR, CAPLYTA.
Industry payments across OH — which companies pay providers there.
